Health Channel of Togo: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Channel of Togo.

Press releases published on July 7, 2026

15 hours ago

Lumanity Strengthens Climate Commitment with SBTi (Science Based Targets Initiative) Validation for Near-Term Emissions Reduction Targets

Indeterminate GlobeNewswire

15 hours ago

Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026

Indeterminate GlobeNewswire

15 hours ago

Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI

Indeterminate GlobeNewswire

15 hours ago

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Indeterminate GlobeNewswire

15 hours ago

Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

Indeterminate GlobeNewswire

15 hours ago

BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™

Indeterminate GlobeNewswire

15 hours ago

Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026

Indeterminate GlobeNewswire

15 hours ago

Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential

Indeterminate GlobeNewswire

15 hours ago

Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy

Indeterminate GlobeNewswire

16 hours ago

Teva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b Development in Vitiligo, Following Encouraging Phase 1b Results

Indeterminate GlobeNewswire

16 hours ago

HMNC Brain Health Announces Publication of Ketabon (KET01) Clinical Trial Results in JAMA Network Open

Indeterminate GlobeNewswire

16 hours ago

AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026

Indeterminate GlobeNewswire

16 hours ago

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

Indeterminate GlobeNewswire

16 hours ago

Endogenex Announces Full Enrollment of the ReCET Clinical Study

Indeterminate GlobeNewswire

16 hours ago

MariMed’s Nature’s Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign

Indeterminate GlobeNewswire

16 hours ago

Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement

Indeterminate GlobeNewswire

16 hours ago

Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum

Indeterminate GlobeNewswire

16 hours ago

Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader

Indeterminate GlobeNewswire

16 hours ago

Aclarion Announces Texas Spine Care Center as New CLARITY Site

Indeterminate GlobeNewswire

16 hours ago

ImageneBio Appoints Matt Robbins as General Counsel

Indeterminate GlobeNewswire